Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 723 of 1,261

  1. US 9187457

    Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  2. US 9187423

    Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  3. US 9187516

    Compositions and methods for inhibiting expression of a gene from the Ebola virus

    The United States of America as represented by the Secretary of the Army · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  4. US 9187746

    Dual targeting siRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  5. US 9187747

    RNAi modulation of ApoB and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  6. US 9187569

    Branched polymers

    Nektar Therapeutics · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  7. US 9187529

    Cationic peptides and use of such peptides for inhibiting exotoxin production

    Regents of the University of Minnesota · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  8. US 9187523

    Substrate peptide sequences for plague plasminogen activator and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  9. US 9187453

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  10. US 9186421

    Establishment of rhesus monkey model of autoimmunity type 1 diabetes

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  11. US 9186417

    Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use

    The Regents of the University of California · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  12. US 9187426

    Organic compounds

    Xenon Pharmaceuticals Inc. · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  13. US 9186413

    Sustained delivery formulations of risperidone compounds

    Indivior UK Limited · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  14. US 9186411

    Pharmaceutical composition

    Takeda Pharmaceutical Company Limited · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  15. US 9186400

    Compositions for stimulation of mammalian innate immune resistance to pathogens

    The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  16. US 9186365

    Antiangiogenic small molecules and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  17. US 9186340

    Ischemia/reperfusion protection compositions and methods of using

    Regents of the University of Minnesota · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  18. US 9186333

    Process for preparing pharmaceutical compositions of fingolimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  19. US 9181577

    Treatment of chronic pelvic pain syndrome

    Northwestern University · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  20. US 9181530

    Infectious hepatitis E virus genotype 3 recombinants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  21. US 9180133

    Method for treating uterine fibroids

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  22. US 9182412

    Borrelia diagnostics and screening methods

    The Regents of the University of California · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  23. US 9180102

    Methods for fabricating nano and microparticles for drug delivery

    The Board of Regents of the University of Texas System · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  24. US 9181327

    Anti-HIV domain antibodies and method of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.